Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

FARN

Faron

Faron Pharmaceuticals Oy is a Finnish drug discovery and development company focused on acute trauma, cancer and inflammatory diseases. With a pipeline of drug development projects, the company's l...

Faron Annual Report 2023

Healthcare Biotechnology LSE 11-50

MNKD

MannKind

MannKind Corporation is a biopharmaceutical company with a primary focus on developing and commercializing inhaled therapeutic products for endocrine and orphan lung diseases in the United States. ...

MannKind Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

ENTA

Enanta Pharmaceuticals

Enanta Pharmaceuticals, a biotechnology firm, is committed to discovering and developing cutting-edge small molecule drugs to treat viral infections and liver diseases. Its disease targets include ...

Enanta Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ORGS

Orgenesis

Biotech company Orgenesis Inc. has made significant strides in the global cell and gene therapies sector with its innovative Point of Care (POCare) platform. The company's POCare technology system ...

Orgenesis Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

LPTX

Leap Therapeutics, Inc.

Cambridge-based biopharmaceutical company, Leap Therapeutics, Inc., has made waves in the cancer treatment space with its acquisition and development of innovative antibody therapies. The company's...

Leap Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ELOX

Eloxx Pharmaceuticals, Inc.

Watertown, Mass.-based Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm with a primary focus on developing ribosome modulation for the treatment of rare and ultra-rare prematu...

Eloxx Pharmaceuticals, Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

CDXS

Codexis

Codexis Inc.: A Leader in Enzyme and Protein Development Redwood City, California-based Codexis Inc. is a renowned developer, discoverer, and seller of enzymes and other proteins. With two operati...

Codexis Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ONC

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. is a biotech company that is focused on developing a new treatment for cancer called pelareorep. The treatment is delivered intravenously and is designed to target cancer th...

Oncolytics Biotech Inc. Annual Report 2023

Healthcare Biotechnology LSE 51-200

ZEAL

Zealand Pharma

Zealand Pharma is a biotech company that specializes in developing peptide-based medicines for metabolic and gastrointestinal diseases. With over 10 drug candidates in clinical development, Zealand...

Zealand Pharma Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

ARTL

Artelo Biosciences

Clinical stage biopharmaceutical company, Artelo Biosciences, Inc., is dedicated to developing and bringing to market treatments that modulate the endocannabinoid system. Among its promising produc...

Artelo Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

CALA

Calithera Biosciences

Calithera Biosciences Inc., a clinical-stage bio-pharmaceutical company based in South San Francisco, is dedicated to the development and discovery of small molecule compounds that target tumor met...

Calithera Biosciences Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

CBMG

Cellular Biomedicine Group Inc

Cellular Biomedicine Group Inc. is a biomedicine company that operates in Greater China and specializes in the treatment of cancerous and degenerative diseases. The company primarily focuses on dev...

Cellular Biomedicine Group Inc Annual Report 2018

Healthcare Biotechnology NASDAQ 1-10

ARCT

Arcturus Therapeutics

Arcturus Therapeutics Holdings Inc. - San Diego's own late-stage clinical messenger RNA medicines and vaccine company - has its sights set on developing infectious disease vaccines as well as other...

Arcturus Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SGMO

Sangamo Therapeutics

Sangamo Therapeutics, Inc. is a US-based clinical-stage genomic medicine firm that aims to develop transformative medicines for patients and their families suffering from serious diseases. The comp...

Sangamo Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

TTNP

Titan Pharmaceuticals Inc.

South San Francisco-based pharmaceutical company Titan Pharmaceuticals, Inc. has developed a novel long-term drug delivery platform called ProNeura. The company's therapeutic products specifically ...

Titan Pharmaceuticals Inc. Annual Report 2023

Healthcare Biotechnology AMEX 11-50